Henrik Skjødt

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Merete Lund Hetland, B Ejbjerg, Kim Hørslev‐Petersen et al. · Annals of the Rheumatic Diseases · 2008 · 364 citations

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator‐initiated, multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study

Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker et al. · Arthritis & Rheumatism · 2006 · 172 citations

Periodontal and Hematological Characteristics Associated With Aggressive Periodontitis, Juvenile Idiopathic Arthritis, and Rheumatoid Arthritis

Anne Havemose‐Poulsen, Jytte Westergaard, Kaj Stoltze et al. · Journal of Periodontology · 2006 · 137 citations

Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro

Henrik Skjødt, J.A. Gallagher, J.N. Beresford et al. · Journal of Endocrinology · 1985 · 127 citations

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

Kim Hørslev‐Petersen, Merete Lund Hetland, Peter Junker et al. · Annals of the Rheumatic Diseases · 2013 · 124 citations · Full text